Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 5, 2009
Sun, October 4, 2009 PEP, EMC, MU, BBT, WYE, BSX With Highest Daily Short Volume On NYSE Friday
October 5, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, has reviewed the NYSE Daily Short Volume Report for Friday, October 2nd, 2009 and come to the following statistical conclusions. There were 6,420 stocks with daily short volume reported and total NYSE trading volume of 1,310,736,035 shares. Total Daily Short Volume was 638,679,514 shares. 48.73% of all trading on the NYSE Friday was short selling. The chart below highlights 6 stocks that had the highest daily short volume on Friday. Pepsico (NYSE: PEP), EMC Corp (NYSE: EMC), Micron Technology (NYSE: MU), BB and T Corp (NYSE: BBT), Wyeth (NYSE: WYE) and Boston Scientific (NYSE: BSX). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.
Date Symbol Short Volume Total Volume Market Percent
20091002 PEP 1,503,861 2,693,975 P 55.82%
20091002 EMC 1,369,426 2,172,497 P 63.03%
20091002 MU 1,281,741 2,712,179 P 47.26%
20091002 BBT 1,182,710 2,246,069 P 52.66%
20091002 WYE 1,061,707 2,451,124 P 43.32%
20091002 BSX 1,055,229 2,761,088 P 38.22%
In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesa� naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales.
Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities.
The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted.
PepsiCo, Inc. (NYSE: PEP) manufactures, markets, and sells various snacks, carbonated and non-carbonated beverages, and foods worldwide. Its PepsiCo Americas Foods unit offers salty and sweet snacks comprising Laya�s potato chips, Doritos tortilla chips, Cheetos cheese flavored snacks, Tostitos tortilla chips, branded dips, Fritos corn chips, Ruffles potato chips, Quaker Chewy granola bars, SunChips multigrain snacks, Rold Gold pretzels, Santitas tortilla chips, Frito-Lay nuts, Grandmaa�s cookies, Gamesa cookies, Munchies snack mix, Funyuns onion flavored rings, Quaker Quakes corn and rice snacks, Sabritas snacks, Miss Vickiea�s potato chips, Stacya�s pita chips, Smartfood popcorn, Chestera�s fries, and branded crackers. This unit also provides cereals, rice, pasta, and other branded products, including Quaker oatmeal, Aunt Jemima mixes and syrups, Quaker grits, Capa�n Crunch cereal, Life cereal, Rice-A-Roni, Pasta Roni, and Near East side dishes. The companya�s PepsiCo Americas Beverages unit sells beverage concentrates, fountain syrups, and finished goods under the Pepsi, Mountain Dew, Gatorade, 7UP, Tropicana Pure Premium, Sierra Mist, Mirinda, Tropicana juice drinks, Propel, Dole, Amp Energy, SoBe Lifewater, Naked juice, and Izze beverage names. This unit also offers ready-to-drink tea, coffee, and water products through joint ventures with Unilever and Starbucks, as well as licenses the Aquafina water brand to its bottlers. The companya�s PepsiCo International unit offers salty and sweet snack brands, including Laya�s, Walkers, Doritos, Cheetos, Ruffles, and Smitha�s; Quaker brand cereals and snacks; and beverage concentrates, fountain syrups, and finished goods under the Pepsi, Mirinda, Mountain Dew, 7UP, and Tropicana names. PepsiCo, Inc. distributes its products through direct-store-delivery, customer warehouse, and food service and vending distribution networks. The company was founded in 1898 and is headquartered in Purchase, New York.
EMC Corporation (NYSE: EMC) develops, delivers, and supports information infrastructure technologies and solutions. The companya�s Information Storage segment offers networked information storage systems, networked attached storage, content addressed storage, or direct attached storage environment. Its software products include EMC SRDF, EMC MirrorView, EMC TimeFinder, and EMC SnapView, which control and enable replication, optimization, and data movement functions in the EMC networked storage system; and EMC Celerra Replicator that copies, protects, and shares data across various distances. Its Content Management and Archiving segment offers software, which optimizes business processes, as well as creates, manages, delivers, and archives information from documents and discussions, e-mail, Web pages, images, XML, reports, records, rich media, and application data. The companya�s RSA Information Security segment delivers products, packaged solutions, and services to guard the integrity and confidentiality of information. This segment offers security product and services, such as enterprise identity and access management products, and encryption and key management software that enable companies to collect, monitor, analyze, and report on security event-related activity. Its VMware Virtual Infrastructure segment offers virtual infrastructure solutions and services that enable customers to address a range of IT problems that include cost and operational inefficiencies, business continuity, software lifecycle management, and desktop management. The company also provides consulting services, technology deployment, managed services, customer support services, and training and certification services. It sells its products and services through direct sales and multiple distribution channels in North America, Latin America, Europe, the Middle East, South Africa, and the Asia Pacific region. EMC Corporation was founded in 1979 and is headquartered in Hopkinton, Massachusetts.
Micron Technology, Inc. (NYSE: MU), together with its subsidiaries, engages in the manufacture and marketing of semiconductor devices worldwide. Its products include dynamic random access memory (DRAM) products that provide data storage and retrieval, which include DDR, DDR2, DDR3, synchronous DRAM, and other specialty DRAM memory products, such as mobile DRAM, pseudo-static RAM, and reduced latency DRAM. The company also offers NAND flash memory products, which are electrically re-writeable and non-volatile semiconductor devices that retain memory content when power is turned off; and complementary metal-oxide semiconductor image sensors that capture and process images into pictures or video for various consumer and industrial applications. Micron Technologya�s products are used in a range of electronic applications, including personal computers, workstations, network servers, mobile phones, flash memory cards, USB storage devices, MP3/4 players, and in automotive applications. It sells its products to original equipment manufacturers and retailers through internal sales force, independent sales representatives, and distributors, as well as Web-based customer direct sales division. Micron Technology has joint ventures with Intel Corp. to develop and manufacture NAND flash memory products; Singapore Economic Development Board, Canon, Inc., and Hewlett-Packard Company to manufacture memory products in Singapore; Nanya Technology Corporation to manufacture stack DRAM products; and Photronics, Inc. to produce photomasks for advanced next generation semiconductors. It also has strategic technology collaboration with Infineon Technologies AG for the development of high-density subscriber identity module cards reaching beyond 128 megabytes. The company was founded in 1978 and is headquartered in Boise, Idaho.
BB&T Corporation (NYSE: BBT) operates as the holding company for Branch Banking and Trust Company that provides banking and trust services for small and mid-size businesses, public agencies, local governments, and individuals in the United States. It accepts various deposit products, including noninterest-bearing checking accounts, interest-bearing checking accounts, savings accounts, money rate savings accounts, investor deposit accounts, certificates of deposit, and individual retirement accounts. The companya�s loan portfolio includes commercial, financial, and agricultural loans; real estate construction and land development, and mortgage loans; and consumer loans. BB&T Corporation, through its other subsidiaries, offers small business lending, commercial middle market lending, real estate lending, retail lending, home equity lending, sales finance, home mortgage lending, commercial mortgage lending, equipment finance, asset management, retail and wholesale agency insurance, institutional trust services, wealth management/private banking, investment brokerage services, capital markets services, commercial finance, consumer finance, international banking services, payment solutions, treasury services, venture capital, bankcard and merchant services, insurance premium finance, supply chain management, and payroll processing. As of December 31, 2008, it operated 1,511 banking offices in North Carolina, South Carolina, Virginia, Maryland, Georgia, West Virginia, Tennessee, Kentucky, Florida, Alabama, Indiana, and Washington, D.C. The company was founded in 1906 and is headquartered in Winston-Salem, North Carolina.
Wyeth (NYSE: WYE) operates as a research-based pharmaceutical and healthcare company in the United States, the United Kingdom, and internationally. Its Pharmaceuticals segment develops, manufactures, distributes, and sells various products, including neuroscience therapies, vaccines, musculoskeletal therapies, nutritional products, gastroenterology drugs, anti-infectives, oncology therapies, hemophilia treatments, immunological products, and womena�s healthcare products. This segment offers its products to wholesalers, pharmacies, hospitals, governments, physicians, retailers, and other human healthcare institutions. The companya�s Consumer Healthcare segment develops, manufactures, distributes, and sells over-the-counter healthcare products comprising analgesics and heat wraps, cough/cold/allergy remedies, nutritional supplements, and hemorrhoidal care and personal care products. This segment sells these products to wholesalers and retailers. Its Animal Health segment develops, manufactures, distributes, and sells various biological and pharmaceutical products for animals, which include vaccines, pharmaceuticals, internal and external parasite control products, and growth implants. This segment markets its products to wholesalers, veterinarians, and other animal healthcare providers. Wyetha�s product pipeline also includes two Phase III clinical programs in oncology that consist of neratinib (HKI-272), which is under development for the treatment of women with advanced HER-2-positive breast cancer; and bosutinib (SKI-606), a targeted kinase inhibitor under development for the treatment of chronic myelogenous leukemia. It has collaboration agreements with Amgen, Inc; Takeda Pharmaceutical Company Limited; Nycomed; Johnson & Johnson; Medtronic Sofamor Danek, Inc.; Trubion; and Elan Corporation, plc. The company was founded in 1926 and is headquartered in Madison, New Jersey.
Boston Scientific Corporation (NYSE: BSX) operates as a developer, manufacturer, and marketer of medical devices used in various interventional medical specialties worldwide. Its products help physicians and other medical professionals improve the patientsa� quality of life by providing alternatives to surgery. The companya�s cardiovascular group consists of drug-eluting and bare-metal stents, coronary revascularization products, Intraluminal ultrasound imaging catheters and systems, Embolic protection system, peripheral and neurovascular interventions, electrophysiology devices, and cardiac rhythm management devices. This groupa�s products are used to treat cardiovascular, peripheral vascular and neurovascular diseases, cardiac arrhythmias, and neuro and aortic aneurysms. Its endosurgery group includes esophageal, gastric, and duodenal intervention products; colorectal, pancreatico-biliary, and pulmonary intervention devices; and products for urinary tract intervention and bladder disease, prostate intervention, pelvic floor reconstruction and urinary incontinence, and gynecology. This groupa�s products are used for the treatment of gastrointestinal diseases, esophagitis, portal hypertension, peptic ulcers, esophageal cancer, polyps, inflammatory bowel disease, diverticulitis, colon cancer, and benign prostatic hyperplasia. The companya�s neuromodulation group comprises Precision Spinal Cord Stimulation system for the treatment of chronic pain of the lower back and legs. Its cardiac rhythm management group offers implantable devices used to treat cardiac arrhythmias and heart failure. Boston Scientific Corporation markets its products through direct sales force, and a network of distributors and dealers. The company was founded in 1979 and is headquartered in Natick, Massachusetts with additional offices in Tokyo, Japan and Paris, France.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net
